PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)

CUSIP: 71715X203

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
10,666,413
Total 13F shares
983,849
Share change
+550,811
Total reported value
$711,966
Price per share
$0.72
Number of holders
26
Value change
+$398,436
Number of buys
12
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 71715X203?
CUSIP 71715X203 identifies PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB) as of Q4 2025

As of 31 Dec 2025, PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 983,849 shares. The largest 10 holders included CITADEL ADVISORS LLC, HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, NORTHERN TRUST CORP, Schonfeld Strategic Advisors LLC, SIMPLEX TRADING, LLC, and TWO SIGMA SECURITIES, LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.